Clinical Trial Update: Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder [Phase 2, Phase 3]

View source ↗

Summary

The document reports on a clinical trial studying how ziprasidone affects glucose and lipid parameters in people with diabetes and in those with schizophrenia o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Manhattan Psychiatric Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2, Phase 3 | Status: COMPLETED